(Total Views: 365)
Posted On: 02/09/2018 11:57:10 AM
Post# of 72446
I'm watching a handful of bio's for discounts. The crazy market volatility doesn't really play into this on or the ones I'm watching.
Timing is the question. A deal on brilacidin, still waiting on full data, could still be a ways off. How long is anyone's guess I'm thinking. With all current trials pretty much done Leo is wise to bring down the small burn rate even smaller. Thanks to Menon as well.
This is what I'd like to see next...
Prurisol data.
Expanded use for brilacidin pending phase 3 with a partner.
Then expanded use for prurisol pending phase 3 with a partner and/or an acquisition of prurisol.
Kevetrin oral formulation complete and ready for testing.
With all the CDA's I think it's likely we'll get a fish on the hook soon.
Timing is the question. A deal on brilacidin, still waiting on full data, could still be a ways off. How long is anyone's guess I'm thinking. With all current trials pretty much done Leo is wise to bring down the small burn rate even smaller. Thanks to Menon as well.
This is what I'd like to see next...
Prurisol data.
Expanded use for brilacidin pending phase 3 with a partner.
Then expanded use for prurisol pending phase 3 with a partner and/or an acquisition of prurisol.
Kevetrin oral formulation complete and ready for testing.
With all the CDA's I think it's likely we'll get a fish on the hook soon.
(4)
(0)
